Evolving Trends in Skull Base Tumor Management-Evolving Trends in Skull Base Tumor Management

Video Transcription

Video Summary

The session was focused on various topics relating to skull base tumors and the role of social and molecular factors in surgery outcomes. Discussions ranged from the use of laser ablation (LIT) in treating recurrent meningiomas, particularly highlighting its minimal invasive nature and the potential complications when identifying cranial nerves during procedures, to molecular markers and targeted therapies for tumors like chordomas, meningiomas, and vestibular schwannomas. The speakers showcased advances in understanding the role of molecular signatures and methylation in predicting tumor behavior and response to treatments. Dr. Zadeh emphasized the need for precise molecular classifications to better guide therapeutic approaches, potentially surpassing WHO grading systems in the future. Data from tumor resection surgeries and social capital's impact on post-surgery outcomes were shared. The presentations stressed the significance of social connectedness, with findings suggesting that strong community support networks can influence surgical recovery and discharge processes. Additionally, there was a focus on assessing viral reactivation's involvement and antiviral therapy in managing delayed facial palsy post vestibular schwannoma resection. Despite the varied approaches, the theme underscored the importance of integrating novel scientific insights with clinical practices to enhance surgical outcomes and patient care.

Keywords

skull base tumors

social factors

molecular factors

laser ablation

recurrent meningiomas

molecular markers

targeted therapies

molecular signatures

tumor behavior

surgical outcomes

social connectedness

viral reactivation